<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-10-07" version="229">
<accession>P49792</accession>
<accession>Q13074</accession>
<accession>Q15280</accession>
<accession>Q53TE2</accession>
<accession>Q59FH7</accession>
<name>RBP2_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 SUMO-protein ligase RanBP2</fullName>
<ecNumber evidence="29 31 33 37 44">2.3.2.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>358 kDa nucleoporin</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear pore complex protein Nup358</fullName>
</alternativeName>
<alternativeName>
<fullName>Nucleoporin Nup358</fullName>
</alternativeName>
<alternativeName>
<fullName>Ran-binding protein 2</fullName>
<shortName>RanBP2</shortName>
</alternativeName>
<alternativeName>
<fullName>p270</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">RANBP2</name>
<name type="synonym">NUP358</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="14209" last="14213">
<title>Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a leucine-rich region.</title>
<authorList>
<person name="Wu J."/>
<person name="Matunis M.J."/>
<person name="Kraemer D."/>
<person name="Blobel G."/>
<person name="Coutavas E."/>
</authorList>
<dbReference type="PubMed" id="7775481"/>
<dbReference type="DOI" id="10.1074/jbc.270.23.14209"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Nature" volume="376" first="184" last="188">
<title>A giant nucleopore protein that binds Ran/TC4.</title>
<authorList>
<person name="Yokoyama N."/>
<person name="Hayashi N."/>
<person name="Seki T."/>
<person name="Nishii K."/>
<person name="Hayashida T."/>
<person name="Kuma K."/>
<person name="Miyata T."/>
<person name="Fukui M."/>
<person name="Nishimoto T."/>
<person name="Pante N."/>
<person name="Aebi U."/>
</authorList>
<dbReference type="PubMed" id="7603572"/>
<dbReference type="DOI" id="10.1038/376184a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>IDENTIFICATION IN THE NUCLEAR PORE COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT LYS-784</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 87-3224</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="3328" last="3332">
<title>The Ran/TC4 GTPase-binding domain: identification by expression cloning and characterization of a conserved sequence motif.</title>
<authorList>
<person name="Beddow A.L."/>
<person name="Richards S.A."/>
<person name="Orem N.R."/>
<person name="Macara I.G."/>
</authorList>
<dbReference type="PubMed" id="7724562"/>
<dbReference type="DOI" id="10.1073/pnas.92.8.3328"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 2205-2546</scope>
<source>
<tissue>Hippocampus</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="Cell" volume="108" first="109" last="120">
<title>The nucleoporin RanBP2 has SUMO1 E3 ligase activity.</title>
<authorList>
<person name="Pichler A."/>
<person name="Gast A."/>
<person name="Seeler J.S."/>
<person name="Dejean A."/>
<person name="Melchior F."/>
</authorList>
<dbReference type="PubMed" id="11792325"/>
<dbReference type="DOI" id="10.1016/s0092-8674(01)00633-x"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUMOYLATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2002" name="EMBO J." volume="21" first="2682" last="2691">
<title>The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase.</title>
<authorList>
<person name="Kirsh O."/>
<person name="Seeler J.-S."/>
<person name="Pichler A."/>
<person name="Gast A."/>
<person name="Mueller S."/>
<person name="Miska E."/>
<person name="Mathieu M."/>
<person name="Harel-Bellan A."/>
<person name="Kouzarides T."/>
<person name="Melchior F."/>
<person name="Dejean A."/>
</authorList>
<dbReference type="PubMed" id="12032081"/>
<dbReference type="DOI" id="10.1093/emboj/21.11.2682"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="J. Cell Biol." volume="156" first="617" last="630">
<title>Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export.</title>
<authorList>
<person name="Frosst P."/>
<person name="Guan T."/>
<person name="Subauste C."/>
<person name="Hahn K."/>
<person name="Gerace L."/>
</authorList>
<dbReference type="PubMed" id="11839768"/>
<dbReference type="DOI" id="10.1083/jcb.200106046"/>
</citation>
<scope>IDENTIFICATION IN THE NUCLEAR PORE COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="1155" last="1167">
<title>RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the nuclear pore complex and functions in nuclear mRNA export.</title>
<authorList>
<person name="Forler D."/>
<person name="Rabut G."/>
<person name="Ciccarelli F.D."/>
<person name="Herold A."/>
<person name="Koecher T."/>
<person name="Niggeweg R."/>
<person name="Bork P."/>
<person name="Ellenberg J."/>
<person name="Izaurralde E."/>
</authorList>
<dbReference type="PubMed" id="14729961"/>
<dbReference type="DOI" id="10.1128/mcb.24.3.1155-1167.2004"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH RANGAP1; NXF1 AND NXT1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Nat. Struct. Mol. Biol." volume="11" first="984" last="991">
<title>The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.</title>
<authorList>
<person name="Pichler A."/>
<person name="Knipscheer P."/>
<person name="Saitoh H."/>
<person name="Sixma T.K."/>
<person name="Melchior F."/>
</authorList>
<dbReference type="PubMed" id="15378033"/>
<dbReference type="DOI" id="10.1038/nsmb834"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH UBE2I</scope>
<scope>SUMOYLATION AT LYS-2592</scope>
<scope>MUTAGENESIS OF PRO-2640; LYS-2645; LEU-2651; LYS-2652; LEU-2653; PRO-2654; PRO-2655; THR-2656; PHE-2657; PHE-2658; CYS-2659; ASP-2676; PHE-2677 AND TYR-2689</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Proc. Natl. Acad. Sci. U.S.A." volume="101" first="14373" last="14378">
<title>Identification of a SUMO-binding motif that recognizes SUMO-modified proteins.</title>
<authorList>
<person name="Song J."/>
<person name="Durrin L.K."/>
<person name="Wilkinson T.A."/>
<person name="Krontiris T.G."/>
<person name="Chen Y."/>
</authorList>
<dbReference type="PubMed" id="15388847"/>
<dbReference type="DOI" id="10.1073/pnas.0403498101"/>
</citation>
<scope>INTERACTION WITH SUMOYLATED RANGAP1</scope>
<scope>MUTAGENESIS OF VAL-2632; ILE-2634 AND VAL-2635</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Nat. Struct. Mol. Biol." volume="12" first="67" last="74">
<title>Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.</title>
<authorList>
<person name="Tatham M.H."/>
<person name="Kim S."/>
<person name="Jaffray E."/>
<person name="Song J."/>
<person name="Chen Y."/>
<person name="Hay R.T."/>
</authorList>
<dbReference type="PubMed" id="15608651"/>
<dbReference type="DOI" id="10.1038/nsmb878"/>
</citation>
<scope>INTERACTION WITH SUMO1 AND UBE2I</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Arch. Biochem. Biophys." volume="453" first="70" last="74">
<title>A general approach for investigating enzymatic pathways and substrates for ubiquitin-like modifiers.</title>
<authorList>
<person name="Li T."/>
<person name="Santockyte R."/>
<person name="Shen R.-F."/>
<person name="Tekle E."/>
<person name="Wang G."/>
<person name="Yang D.C.H."/>
<person name="Chock P.B."/>
</authorList>
<dbReference type="PubMed" id="16620772"/>
<dbReference type="DOI" id="10.1016/j.abb.2006.03.002"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="3595" last="3603">
<title>Parkin ubiquitinates and promotes the degradation of RanBP2.</title>
<authorList>
<person name="Um J.W."/>
<person name="Min D.S."/>
<person name="Rhim H."/>
<person name="Kim J."/>
<person name="Paik S.R."/>
<person name="Chung K.C."/>
</authorList>
<dbReference type="PubMed" id="16332688"/>
<dbReference type="DOI" id="10.1074/jbc.m504994200"/>
</citation>
<scope>INTERACTION WITH PRKN</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND THR-1144</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-781; SER-948; SER-955; SER-1110; THR-1144; SER-1160; THR-1396; SER-1443; SER-1456; SER-1509; SER-1573; SER-1869; SER-2270; THR-2613; SER-2668; SER-2741; THR-2743 AND SER-2900</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proteomics" volume="8" first="1346" last="1361">
<title>Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography.</title>
<authorList>
<person name="Han G."/>
<person name="Ye M."/>
<person name="Zhou H."/>
<person name="Jiang X."/>
<person name="Feng S."/>
<person name="Jiang X."/>
<person name="Tian R."/>
<person name="Wan D."/>
<person name="Zou H."/>
<person name="Gu J."/>
</authorList>
<dbReference type="PubMed" id="18318008"/>
<dbReference type="DOI" id="10.1002/pmic.200700884"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Mol. Biol. Cell" volume="20" first="410" last="418">
<title>RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.</title>
<authorList>
<person name="Klein U.R."/>
<person name="Haindl M."/>
<person name="Nigg E.A."/>
<person name="Muller S."/>
</authorList>
<dbReference type="PubMed" id="18946085"/>
<dbReference type="DOI" id="10.1091/mbc.e08-05-0511"/>
</citation>
<scope>INTERACTION WITH CDCA8</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-955; SER-1107; THR-1396; SER-1871; SER-2270; SER-2668 AND SER-2900</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Curr. Biol." volume="20" first="25" last="31">
<title>mRNA export from mammalian cell nuclei is dependent on GANP.</title>
<authorList>
<person name="Wickramasinghe V.O."/>
<person name="McMurtrie P.I."/>
<person name="Mills A.D."/>
<person name="Takei Y."/>
<person name="Penrhyn-Lowe S."/>
<person name="Amagase Y."/>
<person name="Main S."/>
<person name="Marr J."/>
<person name="Stewart M."/>
<person name="Laskey R.A."/>
</authorList>
<dbReference type="PubMed" id="20005110"/>
<dbReference type="DOI" id="10.1016/j.cub.2009.10.078"/>
</citation>
<scope>INTERACTION WITH MCM3AP</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="PLoS Biol." volume="8" first="E1000350" last="E1000350">
<title>Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore complexes and regulate centrosome and nuclear positioning during mitotic entry.</title>
<authorList>
<person name="Splinter D."/>
<person name="Tanenbaum M.E."/>
<person name="Lindqvist A."/>
<person name="Jaarsma D."/>
<person name="Flotho A."/>
<person name="Yu K.L."/>
<person name="Grigoriev I."/>
<person name="Engelsma D."/>
<person name="Haasdijk E.D."/>
<person name="Keijzer N."/>
<person name="Demmers J."/>
<person name="Fornerod M."/>
<person name="Melchior F."/>
<person name="Hoogenraad C.C."/>
<person name="Medema R.H."/>
<person name="Akhmanova A."/>
</authorList>
<dbReference type="PubMed" id="20386726"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000350"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE NUCLEAR PORE COMPLEX</scope>
<scope>INTERACTION WITH BICD2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="PLoS Biol." volume="8" first="E1000439" last="E1000439">
<title>Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases.</title>
<authorList>
<person name="Davis T.L."/>
<person name="Walker J.R."/>
<person name="Campagna-Slater V."/>
<person name="Finerty P.J."/>
<person name="Paramanathan R."/>
<person name="Bernstein G."/>
<person name="MacKenzie F."/>
<person name="Tempel W."/>
<person name="Ouyang H."/>
<person name="Lee W.H."/>
<person name="Eisenmesser E.Z."/>
<person name="Dhe-Paganon S."/>
</authorList>
<dbReference type="PubMed" id="20676357"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1000439"/>
</citation>
<scope>FUNCTION</scope>
<scope>CAUTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-781; SER-837; SER-948; SER-955; SER-1110; SER-1160; THR-1412; SER-1509; SER-1835; SER-2900 AND SER-3207</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1160; SER-1456; SER-2668; SER-2900 AND SER-3207</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2012" name="Gastroenterology" volume="142" first="572" last="581">
<title>Beta-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.</title>
<authorList>
<person name="Satow R."/>
<person name="Shitashige M."/>
<person name="Jigami T."/>
<person name="Fukami K."/>
<person name="Honda K."/>
<person name="Kitabayashi I."/>
<person name="Yamada T."/>
</authorList>
<dbReference type="PubMed" id="22155184"/>
<dbReference type="DOI" id="10.1053/j.gastro.2011.11.041"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PML</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; THR-779; SER-781; SER-948; SER-955; THR-1098; SER-1103; SER-1107; SER-1110; THR-1144; SER-1160; SER-1249; THR-1396; THR-1412; SER-1450; SER-1456; SER-1509; SER-1520; SER-1573; SER-1833; SER-1835; SER-1869; SER-2270; SER-2526; THR-2613; TYR-2666; SER-2668; SER-2805 AND SER-3207</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-955; SER-1160; SER-1450; SER-1456; SER-1509; SER-2668 AND SER-2900</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-945 AND ARG-1016</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1605; LYS-1664; LYS-1723; LYS-2594 AND LYS-2792</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.o114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414; LYS-1605; LYS-1664 AND LYS-1723</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1350; LYS-1414; LYS-1596; LYS-1605; LYS-1655; LYS-1664; LYS-1714; LYS-1723; LYS-2022; LYS-2522; LYS-2594; LYS-2612; LYS-2792 AND LYS-2815</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1999" name="Nature" volume="398" first="39" last="46">
<title>Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport.</title>
<authorList>
<person name="Vetter I.R."/>
<person name="Nowak C."/>
<person name="Nishimoto T."/>
<person name="Kuhlmann J."/>
<person name="Wittinghofer A."/>
</authorList>
<dbReference type="PubMed" id="10078529"/>
<dbReference type="DOI" id="10.1038/17969"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF 1171-1304</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="348" first="711" last="725">
<title>Solution structure of the Ran-binding domain 2 of RanBP2 and its interaction with the C terminus of Ran.</title>
<authorList>
<person name="Geyer J.P."/>
<person name="Doker R."/>
<person name="Kremer W."/>
<person name="Zhao X."/>
<person name="Kuhlmann J."/>
<person name="Kalbitzer H.R."/>
</authorList>
<dbReference type="PubMed" id="15826666"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.02.033"/>
</citation>
<scope>STRUCTURE BY NMR OF 2028-2154</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2005" name="Nature" volume="435" first="687" last="692">
<title>Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.</title>
<authorList>
<person name="Reverter D."/>
<person name="Lima C.D."/>
</authorList>
<dbReference type="PubMed" id="15931224"/>
<dbReference type="DOI" id="10.1038/nature03588"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 2631-2711 IN COMPLEX WITH SUMO1; RANGAP1 AND UBE2I</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="4740" last="4751">
<title>Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.</title>
<authorList>
<person name="Gareau J.R."/>
<person name="Reverter D."/>
<person name="Lima C.D."/>
</authorList>
<dbReference type="PubMed" id="22194619"/>
<dbReference type="DOI" id="10.1074/jbc.m111.321141"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) OF 2631-2695 IN COMPLEX WITH SUMO1; RANGAP1 AND UBE2I</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="J. Mol. Biol." volume="423" first="752" last="765">
<title>Crystal structure of the N-terminal domain of Nup358/RanBP2.</title>
<authorList>
<person name="Kassube S.A."/>
<person name="Stuwe T."/>
<person name="Lin D.H."/>
<person name="Antonuk C.D."/>
<person name="Napetschnig J."/>
<person name="Blobel G."/>
<person name="Hoelz A."/>
</authorList>
<dbReference type="PubMed" id="22959972"/>
<dbReference type="DOI" id="10.1016/j.jmb.2012.08.026"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) OF 1-145</scope>
<scope>TPR REPEATS</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="J. Mol. Biol." volume="425" first="1318" last="1329">
<title>Structural and functional analysis of the C-terminal domain of Nup358/RanBP2.</title>
<authorList>
<person name="Lin D.H."/>
<person name="Zimmermann S."/>
<person name="Stuwe T."/>
<person name="Stuwe E."/>
<person name="Hoelz A."/>
</authorList>
<dbReference type="PubMed" id="23353830"/>
<dbReference type="DOI" id="10.1016/j.jmb.2013.01.021"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3062-3224</scope>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE NUCLEAR PORE COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DOMAIN</scope>
<scope>CAUTION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="Am. J. Hum. Genet." volume="84" first="44" last="51">
<title>Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2.</title>
<authorList>
<person name="Neilson D.E."/>
<person name="Adams M.D."/>
<person name="Orr C.M.D."/>
<person name="Schelling D.K."/>
<person name="Eiben R.M."/>
<person name="Kerr D.S."/>
<person name="Anderson J."/>
<person name="Bassuk A.G."/>
<person name="Bye A.M."/>
<person name="Childs A.-M."/>
<person name="Clarke A."/>
<person name="Crow Y.J."/>
<person name="Di Rocco M."/>
<person name="Dohna-Schwake C."/>
<person name="Dueckers G."/>
<person name="Fasano A.E."/>
<person name="Gika A.D."/>
<person name="Gionnis D."/>
<person name="Gorman M.P."/>
<person name="Grattan-Smith P.J."/>
<person name="Hackenberg A."/>
<person name="Kuster A."/>
<person name="Lentschig M.G."/>
<person name="Lopez-Laso E."/>
<person name="Marco E.J."/>
<person name="Mastroyianni S."/>
<person name="Perrier J."/>
<person name="Schmitt-Mechelke T."/>
<person name="Servidei S."/>
<person name="Skardoutsou A."/>
<person name="Uldall P."/>
<person name="van der Knaap M.S."/>
<person name="Goglin K.C."/>
<person name="Tefft D.L."/>
<person name="Aubin C."/>
<person name="de Jager P."/>
<person name="Hafler D."/>
<person name="Warman M.L."/>
</authorList>
<dbReference type="PubMed" id="19118815"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2008.12.009"/>
</citation>
<scope>VARIANTS IIAE3 MET-585; ILE-653 AND VAL-656</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="Leukemia" volume="27" first="1186" last="1188">
<title>A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm.</title>
<authorList>
<person name="Gervais C."/>
<person name="Dano L."/>
<person name="Perrusson N."/>
<person name="Helias C."/>
<person name="Jeandidier E."/>
<person name="Galoisy A.C."/>
<person name="Ittel A."/>
<person name="Herbrecht R."/>
<person name="Bilger K."/>
<person name="Mauvieux L."/>
</authorList>
<dbReference type="PubMed" id="23041776"/>
<dbReference type="DOI" id="10.1038/leu.2012.286"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION WITH FGFR1</scope>
</reference>
<comment type="function">
<text evidence="29 31 33 37 41 42 43 44 47 49 50">E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2 conjugation by UBE2I (PubMed:11792325, PubMed:12032081, PubMed:15378033, PubMed:22194619, PubMed:15931224). Involved in transport factor (Ran-GTP, karyopherin)-mediated protein import via the F-G repeat-containing domain which acts as a docking site for substrates (PubMed:7775481). Binds single-stranded RNA (in vitro) (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the nuclear export pathway (PubMed:10078529). Specific docking site for the nuclear export factor exportin-1 (PubMed:10078529). Sumoylates PML at 'Lys-490' which is essential for the proper assembly of PML-NB (PubMed:22155184). Recruits BICD2 to the nuclear envelope and cytoplasmic stacks of nuclear pore complex known as annulate lamellae during G2 phase of cell cycle (PubMed:20386726). Probable inactive PPIase with no peptidyl-prolyl cis-trans isomerase activity (PubMed:20676357, PubMed:23353830).</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein sumoylation.</text>
</comment>
<comment type="subunit">
<text evidence="28 30 32 33 34 36 38 40 41 43 47 48">Part of the nuclear pore complex (PubMed:11839768, PubMed:20386726, PubMed:23353830, PubMed:7603572). Forms a complex with NXT1, NXF1 and RANGAP1 (PubMed:14729961). Forms a tight complex with RANBP1 and UBE2I (PubMed:15388847, PubMed:10078529, PubMed:15826666). Interacts with SUMO1 but not SUMO2 (PubMed:15388847, PubMed:10078529, PubMed:15826666). Interacts with PRKN (PubMed:16332688). Interacts with sumoylated RANGAP1 (PubMed:15378033, PubMed:10078529, PubMed:15826666). Interacts with CDCA8 (PubMed:19413330). Interacts with PML (isoform PML-4) (PubMed:22155184). Interacts with BICD2 (PubMed:20386726). Interacts with MCM3AP isoform GANP (PubMed:20005110).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973138">
<id>P49792</id>
</interactant>
<interactant intactId="EBI-2372628">
<id>Q8TD16</id>
<label>BICD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973138">
<id>P49792</id>
</interactant>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973138">
<id>P49792</id>
</interactant>
<interactant intactId="EBI-5658852">
<id>Q53GG5</id>
<label>PDLIM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973138">
<id>P49792</id>
</interactant>
<interactant intactId="EBI-716346">
<id>O60260</id>
<label>PRKN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973138">
<id>P49792</id>
</interactant>
<interactant intactId="EBI-286642">
<id>P62826</id>
<label>RAN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973138">
<id>P49792</id>
</interactant>
<interactant intactId="EBI-80168">
<id>P63279</id>
<label>UBE2I</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-973138">
<id>P49792</id>
</interactant>
<interactant intactId="EBI-642995">
<id>Q921C5-1</id>
<label>Bicd2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="49">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="30">Nucleus membrane</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="30 41 47 48">Nucleus</location>
<location evidence="30 41 47 48">Nuclear pore complex</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="41">Nucleus envelope</location>
</subcellularLocation>
<text evidence="30 49">Detected in diffuse and discrete intranuclear foci (PubMed:11839768). Cytoplasmic filaments (PubMed:7775481).</text>
</comment>
<comment type="domain">
<text evidence="51">Contains FG repeats. FG repeats are interaction sites for karyopherins (importins, exportins) and form probably an affinity gradient, guiding the transport proteins unidirectionally with their cargo through the NPC. FG repeat regions are highly flexible and lack ordered secondary structure. The overall conservation of FG repeats regarding exact sequence, spacing, and repeat unit length is limited.</text>
</comment>
<comment type="domain">
<text evidence="47">The PPIase cyclophilin-type domain has high structural similarity with PPIA, but has extremely low and barely detectable proline isomerase activity (in vitro) (PubMed:23353830). Only about half of the residues that surround the PPIA active site cleft are conserved.</text>
</comment>
<comment type="PTM">
<text evidence="38">Polyubiquitinated by PRKN, which leads to proteasomal degradation.</text>
</comment>
<comment type="PTM">
<text evidence="23">The inner channel of the NPC has a different redox environment from the cytoplasm and allows the formation of interchain disulfide bonds between some nucleoporins, the significant increase of these linkages upon oxidative stress reduces the permeability of the NPC.</text>
</comment>
<comment type="disease" evidence="39">
<disease id="DI-01172">
<name>Encephalopathy, acute, infection-induced, 3</name>
<acronym>IIAE3</acronym>
<description>A rapidly progressive encephalopathy manifesting in susceptible individuals with seizures and coma. It can occur within days in otherwise healthy children after common viral infections such as influenza and parainfluenza, without evidence of viral infection of the brain or inflammatory cell infiltration. Brain T2-weighted magnetic resonance imaging reveals characteristic symmetric lesions present in the thalami, pons and brainstem.</description>
<dbReference type="MIM" id="608033"/>
</disease>
<text evidence="39">The disease is caused by mutations affecting the gene represented in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by themselves are insufficient to make the phenotype fully penetrant; additional genetic and environmental factors are required (PubMed:19118815).</text>
</comment>
<comment type="disease">
<text evidence="46">A chromosomal aberration involving RANBP2 is a cause of chromosome 8p11 myeloproliferative syndrome. Translocation t(2;8)(q12;p11) with FGFR1. Chromosome 8p11 myeloproliferative syndrome is characterized by myeloid hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma. In general it progresses to acute myeloid leukemia.</text>
</comment>
<comment type="similarity">
<text evidence="51">Belongs to the RanBP2 E3 ligase family.</text>
</comment>
<comment type="caution">
<text evidence="42 47">Despite the presence of a PPIase cyclophilin-type domain, it has probably no peptidyl-prolyl cis-trans isomerase activity.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/RANBP2ID483.html"/>
</comment>
<dbReference type="EC" id="2.3.2.-" evidence="29 31 33 37 44"/>
<dbReference type="EMBL" id="L41840">
<property type="protein sequence ID" value="AAC41758.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="D42063">
<property type="protein sequence ID" value="BAA07662.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC010095">
<property type="protein sequence ID" value="AAY14984.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209483">
<property type="protein sequence ID" value="BAD92720.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U19248">
<property type="protein sequence ID" value="AAA85838.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2079.1"/>
<dbReference type="PIR" id="S58884">
<property type="entry name" value="S58884"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006258.3">
<property type="nucleotide sequence ID" value="NM_006267.4"/>
</dbReference>
<dbReference type="PDB" id="1RRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="B/D=1171-1304"/>
</dbReference>
<dbReference type="PDB" id="1XKE">
<property type="method" value="NMR"/>
<property type="chains" value="A=2028-2154"/>
</dbReference>
<dbReference type="PDB" id="1Z5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.01"/>
<property type="chains" value="D=2631-2711"/>
</dbReference>
<dbReference type="PDB" id="2LAS">
<property type="method" value="NMR"/>
<property type="chains" value="B=2705-2717"/>
</dbReference>
<dbReference type="PDB" id="3UIN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="D=2629-2695"/>
</dbReference>
<dbReference type="PDB" id="3UIO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="D=2631-2695"/>
</dbReference>
<dbReference type="PDB" id="3UIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="D=2631-2695"/>
</dbReference>
<dbReference type="PDB" id="4GA0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.15"/>
<property type="chains" value="A=1-145"/>
</dbReference>
<dbReference type="PDB" id="4I9Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A/B/C/D/E/F=3062-3224"/>
</dbReference>
<dbReference type="PDB" id="4L6E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=2907-3050"/>
</dbReference>
<dbReference type="PDB" id="4LQW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=3057-3224"/>
</dbReference>
<dbReference type="PDB" id="5CLL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="B/D=1155-1321"/>
</dbReference>
<dbReference type="PDB" id="5CLQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="B/D=1155-1321"/>
</dbReference>
<dbReference type="PDBsum" id="1RRP"/>
<dbReference type="PDBsum" id="1XKE"/>
<dbReference type="PDBsum" id="1Z5S"/>
<dbReference type="PDBsum" id="2LAS"/>
<dbReference type="PDBsum" id="3UIN"/>
<dbReference type="PDBsum" id="3UIO"/>
<dbReference type="PDBsum" id="3UIP"/>
<dbReference type="PDBsum" id="4GA0"/>
<dbReference type="PDBsum" id="4I9Y"/>
<dbReference type="PDBsum" id="4L6E"/>
<dbReference type="PDBsum" id="4LQW"/>
<dbReference type="PDBsum" id="5CLL"/>
<dbReference type="PDBsum" id="5CLQ"/>
<dbReference type="SMR" id="P49792"/>
<dbReference type="BioGRID" id="111839">
<property type="interactions" value="193"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-4747">
<property type="entry name" value="SUMO1 E3 ligase (RANBP2) complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-4922">
<property type="entry name" value="SUMO2 E3 ligase (RANBP2) complex"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-873">
<property type="entry name" value="Nuclear pore complex"/>
</dbReference>
<dbReference type="DIP" id="DIP-37654N"/>
<dbReference type="IntAct" id="P49792">
<property type="interactions" value="88"/>
</dbReference>
<dbReference type="MINT" id="P49792"/>
<dbReference type="STRING" id="9606.ENSP00000283195"/>
<dbReference type="TCDB" id="1.I.1.1.3">
<property type="family name" value="the nuclear pore complex (npc) family"/>
</dbReference>
<dbReference type="GlyConnect" id="2890">
<property type="glycosylation" value="1 O-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="P49792">
<property type="glycosylation" value="9 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (8 sites)"/>
</dbReference>
<dbReference type="iPTMnet" id="P49792"/>
<dbReference type="MetOSite" id="P49792"/>
<dbReference type="PhosphoSitePlus" id="P49792"/>
<dbReference type="SwissPalm" id="P49792"/>
<dbReference type="BioMuta" id="RANBP2"/>
<dbReference type="DMDM" id="83305554"/>
<dbReference type="OGP" id="P49792"/>
<dbReference type="CPTAC" id="CPTAC-996"/>
<dbReference type="EPD" id="P49792"/>
<dbReference type="jPOST" id="P49792"/>
<dbReference type="MassIVE" id="P49792"/>
<dbReference type="MaxQB" id="P49792"/>
<dbReference type="PaxDb" id="P49792"/>
<dbReference type="PeptideAtlas" id="P49792"/>
<dbReference type="PRIDE" id="P49792"/>
<dbReference type="ProteomicsDB" id="56121"/>
<dbReference type="Antibodypedia" id="33105">
<property type="antibodies" value="198 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000283195">
<property type="protein sequence ID" value="ENSP00000283195"/>
<property type="gene ID" value="ENSG00000153201"/>
</dbReference>
<dbReference type="GeneID" id="5903"/>
<dbReference type="KEGG" id="hsa:5903"/>
<dbReference type="UCSC" id="uc002tem.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5903"/>
<dbReference type="DisGeNET" id="5903"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000153201.15"/>
<dbReference type="GeneCards" id="RANBP2"/>
<dbReference type="GeneReviews" id="RANBP2"/>
<dbReference type="HGNC" id="HGNC:9848">
<property type="gene designation" value="RANBP2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000153201">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="RANBP2"/>
<dbReference type="MIM" id="601181">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608033">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P49792"/>
<dbReference type="OpenTargets" id="ENSG00000153201"/>
<dbReference type="Orphanet" id="263524">
<property type="disease" value="Acute necrotizing encephalopathy of childhood"/>
</dbReference>
<dbReference type="Orphanet" id="88619">
<property type="disease" value="Familial acute necrotizing encephalopathy"/>
</dbReference>
<dbReference type="Orphanet" id="178342">
<property type="disease" value="Inflammatory myofibroblastic tumor"/>
</dbReference>
<dbReference type="PharmGKB" id="PA34209"/>
<dbReference type="eggNOG" id="KOG0864">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="KOG0865">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154389"/>
<dbReference type="HOGENOM" id="CLU_000378_1_0_1"/>
<dbReference type="InParanoid" id="P49792"/>
<dbReference type="KO" id="K12172"/>
<dbReference type="OMA" id="FRFVDKE"/>
<dbReference type="OrthoDB" id="201737at2759"/>
<dbReference type="PhylomeDB" id="P49792"/>
<dbReference type="TreeFam" id="TF314797"/>
<dbReference type="PathwayCommons" id="P49792"/>
<dbReference type="Reactome" id="R-HSA-1169408">
<property type="pathway name" value="ISG15 antiviral mechanism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-141444">
<property type="pathway name" value="Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-159227">
<property type="pathway name" value="Transport of the SLBP independent Mature mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-159230">
<property type="pathway name" value="Transport of the SLBP Dependant Mature mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-159231">
<property type="pathway name" value="Transport of Mature mRNA Derived from an Intronless Transcript"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-159236">
<property type="pathway name" value="Transport of Mature mRNA derived from an Intron-Containing Transcript"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-165054">
<property type="pathway name" value="Rev-mediated nuclear export of HIV RNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168271">
<property type="pathway name" value="Transport of Ribonucleoproteins into the Host Nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168276">
<property type="pathway name" value="NS1 Mediated Effects on Host Pathways"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168325">
<property type="pathway name" value="Viral Messenger RNA Synthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168333">
<property type="pathway name" value="NEP/NS2 Interacts with the Cellular Export Machinery"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-170822">
<property type="pathway name" value="Regulation of Glucokinase by Glucokinase Regulatory Protein"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180746">
<property type="pathway name" value="Nuclear import of Rev protein"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180910">
<property type="pathway name" value="Vpr-mediated nuclear import of PICs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-191859">
<property type="pathway name" value="snRNP Assembly"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2467813">
<property type="pathway name" value="Separation of Sister Chromatids"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2500257">
<property type="pathway name" value="Resolution of Sister Chromatid Cohesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3108214">
<property type="pathway name" value="SUMOylation of DNA damage response and repair proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3232142">
<property type="pathway name" value="SUMOylation of ubiquitinylation proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3301854">
<property type="pathway name" value="Nuclear Pore Complex (NPC) Disassembly"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371453">
<property type="pathway name" value="Regulation of HSF1-mediated heat shock response"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4085377">
<property type="pathway name" value="SUMOylation of SUMOylation proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4551638">
<property type="pathway name" value="SUMOylation of chromatin organization proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4570464">
<property type="pathway name" value="SUMOylation of RNA binding proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4615885">
<property type="pathway name" value="SUMOylation of DNA replication proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578749">
<property type="pathway name" value="Transcriptional regulation by small RNAs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5619107">
<property type="pathway name" value="Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5663220">
<property type="pathway name" value="RHO GTPases Activate Formins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6784531">
<property type="pathway name" value="tRNA processing in the nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-68877">
<property type="pathway name" value="Mitotic Prometaphase"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609690">
<property type="pathway name" value="HCMV Early Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9610379">
<property type="pathway name" value="HCMV Late Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9648025">
<property type="pathway name" value="EML4 and NUDC in mitotic spindle formation"/>
</dbReference>
<dbReference type="SIGNOR" id="P49792"/>
<dbReference type="UniPathway" id="UPA00886"/>
<dbReference type="BioGRID-ORCS" id="5903">
<property type="hits" value="400 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="RANBP2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P49792"/>
<dbReference type="GeneWiki" id="RANBP2"/>
<dbReference type="GenomeRNAi" id="5903"/>
<dbReference type="Pharos" id="P49792">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P49792"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="RNAct" id="P49792">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000153201">
<property type="expression patterns" value="Expressed in biceps brachii and 255 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P49792">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P49792">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005642">
<property type="term" value="C:annulate lamellae"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1990723">
<property type="term" value="C:cytoplasmic periphery of the nuclear pore complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043657">
<property type="term" value="C:host cell"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005635">
<property type="term" value="C:nuclear envelope"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042405">
<property type="term" value="C:nuclear inclusion body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005643">
<property type="term" value="C:nuclear pore"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044614">
<property type="term" value="C:nuclear pore cytoplasmic filaments"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0044615">
<property type="term" value="C:nuclear pore nuclear basket"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008536">
<property type="term" value="F:Ran GTPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0019789">
<property type="term" value="F:SUMO transferase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051642">
<property type="term" value="P:centrosome localization"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0075733">
<property type="term" value="P:intracellular transport of virus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006406">
<property type="term" value="P:mRNA export from nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006607">
<property type="term" value="P:NLS-bearing protein import into nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033133">
<property type="term" value="P:positive regulation of glucokinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0006457">
<property type="term" value="P:protein folding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0000413">
<property type="term" value="P:protein peptidyl-prolyl isomerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0016925">
<property type="term" value="P:protein sumoylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900034">
<property type="term" value="P:regulation of cellular response to heat"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060964">
<property type="term" value="P:regulation of gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006111">
<property type="term" value="P:regulation of gluconeogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006110">
<property type="term" value="P:regulation of glycolytic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001975">
<property type="term" value="P:response to amphetamine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006409">
<property type="term" value="P:tRNA export from nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019083">
<property type="term" value="P:viral transcription"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="Gene3D" id="2.40.100.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00151"/>
<dbReference type="InterPro" id="IPR029000">
<property type="entry name" value="Cyclophilin-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR020892">
<property type="entry name" value="Cyclophilin-type_PPIase_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002130">
<property type="entry name" value="Cyclophilin-type_PPIase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR022011">
<property type="entry name" value="IR1-M"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000156">
<property type="entry name" value="Ran_bind_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR013026">
<property type="entry name" value="TPR-contain_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011990">
<property type="entry name" value="TPR-like_helical_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR019734">
<property type="entry name" value="TPR_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR001876">
<property type="entry name" value="Znf_RanBP2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036443">
<property type="entry name" value="Znf_RanBP2_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF12185">
<property type="entry name" value="IR1-M"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00160">
<property type="entry name" value="Pro_isomerase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00638">
<property type="entry name" value="Ran_BP1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="Pfam" id="PF00641">
<property type="entry name" value="zf-RanBP"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="PRINTS" id="PR00153">
<property type="entry name" value="CSAPPISMRASE"/>
</dbReference>
<dbReference type="SMART" id="SM00160">
<property type="entry name" value="RanBD"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00028">
<property type="entry name" value="TPR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00547">
<property type="entry name" value="ZnF_RBZ"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48452">
<property type="entry name" value="SSF48452"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50891">
<property type="entry name" value="SSF50891"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF90209">
<property type="entry name" value="SSF90209"/>
<property type="match status" value="7"/>
</dbReference>
<dbReference type="PROSITE" id="PS00170">
<property type="entry name" value="CSA_PPIASE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50072">
<property type="entry name" value="CSA_PPIASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50196">
<property type="entry name" value="RANBD1"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS50005">
<property type="entry name" value="TPR"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50293">
<property type="entry name" value="TPR_REGION"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01358">
<property type="entry name" value="ZF_RANBP2_1"/>
<property type="match status" value="8"/>
</dbReference>
<dbReference type="PROSITE" id="PS50199">
<property type="entry name" value="ZF_RANBP2_2"/>
<property type="match status" value="8"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0509">mRNA transport</keyword>
<keyword id="KW-0906">Nuclear pore complex</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0653">Protein transport</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0802">TPR repeat</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0811">Translocation</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 SUMO-protein ligase RanBP2" id="PRO_0000204913">
<location>
<begin position="1"/>
<end position="3224"/>
</location>
</feature>
<feature type="repeat" description="TPR 1" evidence="27 45">
<location>
<begin position="26"/>
<end position="59"/>
</location>
</feature>
<feature type="repeat" description="TPR 2" evidence="27 45">
<location>
<begin position="60"/>
<end position="93"/>
</location>
</feature>
<feature type="repeat" description="TPR 3" evidence="27 45">
<location>
<begin position="94"/>
<end position="128"/>
</location>
</feature>
<feature type="repeat" description="TPR 4" evidence="27 45">
<location>
<begin position="165"/>
<end position="201"/>
</location>
</feature>
<feature type="repeat" description="TPR 5" evidence="27 45">
<location>
<begin position="287"/>
<end position="319"/>
</location>
</feature>
<feature type="repeat" description="TPR 6" evidence="27 45">
<location>
<begin position="583"/>
<end position="616"/>
</location>
</feature>
<feature type="repeat" description="TPR 7" evidence="27 45">
<location>
<begin position="648"/>
<end position="681"/>
</location>
</feature>
<feature type="repeat" description="1" evidence="51">
<location>
<begin position="1001"/>
<end position="1002"/>
</location>
</feature>
<feature type="repeat" description="2" evidence="51">
<location>
<begin position="1101"/>
<end position="1102"/>
</location>
</feature>
<feature type="repeat" description="3" evidence="51">
<location>
<begin position="1142"/>
<end position="1143"/>
</location>
</feature>
<feature type="domain" description="RanBD1 1" evidence="25">
<location>
<begin position="1171"/>
<end position="1307"/>
</location>
</feature>
<feature type="repeat" description="4" evidence="51">
<location>
<begin position="1459"/>
<end position="1460"/>
</location>
</feature>
<feature type="repeat" description="5" evidence="51">
<location>
<begin position="1523"/>
<end position="1524"/>
</location>
</feature>
<feature type="repeat" description="6" evidence="51">
<location>
<begin position="1586"/>
<end position="1587"/>
</location>
</feature>
<feature type="repeat" description="7" evidence="51">
<location>
<begin position="1852"/>
<end position="1853"/>
</location>
</feature>
<feature type="repeat" description="8" evidence="51">
<location>
<begin position="1861"/>
<end position="1862"/>
</location>
</feature>
<feature type="repeat" description="9" evidence="51">
<location>
<begin position="1900"/>
<end position="1901"/>
</location>
</feature>
<feature type="repeat" description="10" evidence="51">
<location>
<begin position="1938"/>
<end position="1939"/>
</location>
</feature>
<feature type="repeat" description="11" evidence="51">
<location>
<begin position="1961"/>
<end position="1962"/>
</location>
</feature>
<feature type="domain" description="RanBD1 2" evidence="25">
<location>
<begin position="2012"/>
<end position="2148"/>
</location>
</feature>
<feature type="repeat" description="12" evidence="51">
<location>
<begin position="2260"/>
<end position="2261"/>
</location>
</feature>
<feature type="domain" description="RanBD1 3" evidence="25">
<location>
<begin position="2309"/>
<end position="2445"/>
</location>
</feature>
<feature type="repeat" description="13" evidence="51">
<location>
<begin position="2516"/>
<end position="2517"/>
</location>
</feature>
<feature type="repeat" description="14" evidence="51">
<location>
<begin position="2535"/>
<end position="2536"/>
</location>
</feature>
<feature type="repeat" description="15" evidence="51">
<location>
<begin position="2545"/>
<end position="2546"/>
</location>
</feature>
<feature type="repeat" description="1" evidence="45">
<location>
<begin position="2633"/>
<end position="2685"/>
</location>
</feature>
<feature type="repeat" description="2" evidence="45">
<location>
<begin position="2711"/>
<end position="2761"/>
</location>
</feature>
<feature type="repeat" description="16" evidence="51">
<location>
<begin position="2840"/>
<end position="2841"/>
</location>
</feature>
<feature type="repeat" description="17" evidence="51">
<location>
<begin position="2842"/>
<end position="2843"/>
</location>
</feature>
<feature type="repeat" description="18" evidence="51">
<location>
<begin position="2863"/>
<end position="2864"/>
</location>
</feature>
<feature type="repeat" description="19" evidence="51">
<location>
<begin position="2880"/>
<end position="2881"/>
</location>
</feature>
<feature type="domain" description="RanBD1 4" evidence="25">
<location>
<begin position="2911"/>
<end position="3046"/>
</location>
</feature>
<feature type="domain" description="PPIase cyclophilin-type" evidence="24">
<location>
<begin position="3067"/>
<end position="3223"/>
</location>
</feature>
<feature type="repeat" description="20" evidence="51">
<location>
<begin position="3106"/>
<end position="3107"/>
</location>
</feature>
<feature type="repeat" description="21" evidence="51">
<location>
<begin position="3189"/>
<end position="3190"/>
</location>
</feature>
<feature type="repeat" description="22" evidence="51">
<location>
<begin position="3205"/>
<end position="3206"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 1" evidence="26">
<location>
<begin position="1351"/>
<end position="1381"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 2" evidence="26">
<location>
<begin position="1415"/>
<end position="1444"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 3" evidence="26">
<location>
<begin position="1479"/>
<end position="1508"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 4" evidence="26">
<location>
<begin position="1543"/>
<end position="1572"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 5" evidence="26">
<location>
<begin position="1606"/>
<end position="1635"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 6" evidence="26">
<location>
<begin position="1665"/>
<end position="1694"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 7" evidence="26">
<location>
<begin position="1724"/>
<end position="1753"/>
</location>
</feature>
<feature type="zinc finger region" description="RanBP2-type 8" evidence="26">
<location>
<begin position="1781"/>
<end position="1810"/>
</location>
</feature>
<feature type="region of interest" description="22 X 2 AA repeats of F-G" evidence="51">
<location>
<begin position="1001"/>
<end position="3206"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with BICD2" evidence="41">
<location>
<begin position="2147"/>
<end position="2287"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with sumoylated RANGAP1">
<location>
<begin position="2631"/>
<end position="2635"/>
</location>
</feature>
<feature type="region of interest" description="2 X 50 AA approximate repeats">
<location>
<begin position="2633"/>
<end position="2761"/>
</location>
</feature>
<feature type="region of interest" description="Required for E3 SUMO-ligase activity">
<location>
<begin position="2633"/>
<end position="2710"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with UBE2I">
<location>
<begin position="2633"/>
<end position="2685"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SUMO1" evidence="35">
<location>
<begin position="2686"/>
<end position="2761"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form RANBP2-FGFR1 protein" evidence="46">
<location>
<begin position="932"/>
<end position="933"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11 12 13">
<location>
<position position="19"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10 11 12 13 15">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="779"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13 15">
<location>
<position position="781"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="788"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="837"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="16">
<location>
<position position="945"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13 15">
<location>
<position position="948"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 13 15 17">
<location>
<position position="955"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="23">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="16">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="15">
<location>
<position position="1098"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1103"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12 15">
<location>
<position position="1107"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13 15">
<location>
<position position="1110"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10 11 15">
<location>
<position position="1144"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13 14 15 17">
<location>
<position position="1160"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1249"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11 12 15">
<location>
<position position="1396"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13 15">
<location>
<position position="1412"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="1443"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 17">
<location>
<position position="1450"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 14 15 17">
<location>
<position position="1456"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 13 15 17">
<location>
<position position="1509"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1520"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 15">
<location>
<position position="1573"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1833"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 15">
<location>
<position position="1835"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 15">
<location>
<position position="1869"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="1871"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="23">
<location>
<position position="1977"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="23">
<location>
<position position="2005"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2008"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="23">
<location>
<position position="2153"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2246"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2251"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 15">
<location>
<position position="2270"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2280"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2290"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="23">
<location>
<position position="2293"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2297"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2462"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2493"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="2510"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="2526"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11 15">
<location>
<position position="2613"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="15">
<location>
<position position="2666"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 14 15 17">
<location>
<position position="2668"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="2741"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="2743"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="2805"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11 12 13 14 17">
<location>
<position position="2900"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 14 15">
<location>
<position position="3207"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="1350"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="19 20 21 22">
<location>
<position position="1414"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="1596"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="18">
<location>
<position position="1605"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 22">
<location>
<position position="1605"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="1655"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="18">
<location>
<position position="1664"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 22">
<location>
<position position="1664"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="1714"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="18">
<location>
<position position="1723"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="20 22">
<location>
<position position="1723"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="2022"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="2522"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="33">
<location>
<position position="2592"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="18">
<location>
<position position="2594"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="22">
<location>
<position position="2594"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="2612"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="18 22">
<location>
<position position="2792"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="2815"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057954." id="VAR_029765">
<original>V</original>
<variation>L</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057956." id="VAR_029766">
<original>E</original>
<variation>K</variation>
<location>
<position position="580"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057957." id="VAR_029767">
<original>C</original>
<variation>Y</variation>
<location>
<position position="581"/>
</location>
</feature>
<feature type="sequence variant" description="In IIAE3; dbSNP:rs121434502." id="VAR_054997" evidence="39">
<original>T</original>
<variation>M</variation>
<location>
<position position="585"/>
</location>
</feature>
<feature type="sequence variant" description="In IIAE3; dbSNP:rs121434503." id="VAR_054998" evidence="39">
<original>T</original>
<variation>I</variation>
<location>
<position position="653"/>
</location>
</feature>
<feature type="sequence variant" description="In IIAE3; dbSNP:rs121434504." id="VAR_054999" evidence="39">
<original>I</original>
<variation>V</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17414315." id="VAR_050575">
<original>S</original>
<variation>G</variation>
<location>
<position position="725"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2912838." id="VAR_023939" evidence="48">
<original>R</original>
<variation>K</variation>
<location>
<position position="784"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2889846." id="VAR_029768">
<original>P</original>
<variation>L</variation>
<location>
<position position="1870"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12770." id="VAR_014886">
<original>P</original>
<variation>A</variation>
<location>
<position position="1892"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12770." id="VAR_050576">
<original>P</original>
<variation>R</variation>
<location>
<position position="1892"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with sumoylated RANGAP1." evidence="34">
<original>V</original>
<variation>K</variation>
<location>
<position position="2632"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with sumoylated RANGAP1." evidence="34">
<original>I</original>
<variation>K</variation>
<location>
<position position="2634"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with sumoylated RANGAP1." evidence="34">
<original>V</original>
<variation>K</variation>
<location>
<position position="2635"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on SUMO E3 ligase activity." evidence="33">
<original>P</original>
<variation>A</variation>
<location>
<position position="2640"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on SUMO E3 ligase activity." evidence="33">
<original>K</original>
<variation>A</variation>
<location>
<position position="2645"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to UBE2I and SUMO E3 ligase activity." evidence="33">
<original>L</original>
<variation>A</variation>
<location>
<position position="2651"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on SUMO E3 ligase activity." evidence="33">
<original>K</original>
<variation>A</variation>
<location>
<position position="2652"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to UBE2I and SUMO E3 ligase activity." evidence="33">
<original>L</original>
<variation>A</variation>
<location>
<position position="2653"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs SUMO E3 ligase activity." evidence="33">
<original>P</original>
<variation>A</variation>
<location>
<position position="2654"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on SUMO E3 ligase activity." evidence="33">
<original>P</original>
<variation>A</variation>
<location>
<position position="2655"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs SUMO E3 ligase activity." evidence="33">
<original>T</original>
<variation>A</variation>
<location>
<position position="2656"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to UBE2I and SUMO E3 ligase activity." evidence="33">
<original>F</original>
<variation>A</variation>
<location>
<position position="2657"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to UBE2I and SUMO E3 ligase activity." evidence="33">
<original>F</original>
<variation>A</variation>
<location>
<position position="2658"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs SUMO E3 ligase activity." evidence="33">
<original>C</original>
<variation>S</variation>
<variation>A</variation>
<location>
<position position="2659"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs SUMO E3 ligase activity." evidence="33">
<original>D</original>
<variation>A</variation>
<location>
<position position="2676"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs SUMO E3 ligase activity." evidence="33">
<original>F</original>
<variation>A</variation>
<location>
<position position="2677"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs SUMO E3 ligase activity." evidence="33">
<original>Y</original>
<variation>A</variation>
<location>
<position position="2689"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAC41758." ref="1" evidence="51">
<original>H</original>
<variation>R</variation>
<location>
<position position="777"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA85838." ref="5" evidence="51">
<original>S</original>
<variation>A</variation>
<location>
<position position="2207"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA85838." ref="5" evidence="51">
<original>T</original>
<variation>P</variation>
<location>
<position position="2210"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA85838." ref="5" evidence="51">
<original>E</original>
<variation>V</variation>
<location>
<position position="2216"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA85838." ref="5" evidence="51">
<original>F</original>
<variation>C</variation>
<location>
<position position="2436"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA85838." ref="5" evidence="51">
<original>T</original>
<variation>P</variation>
<location>
<position position="2475"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAA85838." ref="5" evidence="51">
<original>K</original>
<variation>N</variation>
<location>
<position position="2531"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5." ref="5" evidence="51">
<original>F</original>
<variation>C</variation>
<location>
<position position="2545"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="5"/>
<end position="18"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="22"/>
<end position="26"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="29"/>
<end position="38"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="42"/>
<end position="55"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="60"/>
<end position="72"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="76"/>
<end position="89"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="94"/>
<end position="107"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="112"/>
<end position="124"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="129"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1191"/>
<end position="1205"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="1206"/>
<end position="1209"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1210"/>
<end position="1224"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="1225"/>
<end position="1227"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1230"/>
<end position="1236"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="1237"/>
<end position="1239"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1242"/>
<end position="1247"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1255"/>
<end position="1257"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1260"/>
<end position="1270"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="1277"/>
<end position="1284"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="1288"/>
<end position="1302"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2028"/>
<end position="2030"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2032"/>
<end position="2046"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2047"/>
<end position="2050"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2051"/>
<end position="2065"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2071"/>
<end position="2077"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2078"/>
<end position="2081"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2082"/>
<end position="2088"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2095"/>
<end position="2097"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2105"/>
<end position="2111"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2113"/>
<end position="2115"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="2117"/>
<end position="2125"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="2129"/>
<end position="2145"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="2146"/>
<end position="2148"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="2632"/>
<end position="2637"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="2642"/>
<end position="2650"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="2657"/>
<end position="2661"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2663"/>
<end position="2665"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="2677"/>
<end position="2682"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="2683"/>
<end position="2686"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="2710"/>
<end position="2712"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="2926"/>
<end position="2929"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2930"/>
<end position="2944"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="2945"/>
<end position="2948"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2949"/>
<end position="2963"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="2964"/>
<end position="2967"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2968"/>
<end position="2974"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="2976"/>
<end position="2978"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2981"/>
<end position="2986"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="2994"/>
<end position="2996"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="3000"/>
<end position="3009"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="3016"/>
<end position="3026"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="3027"/>
<end position="3047"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3065"/>
<end position="3072"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3075"/>
<end position="3084"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="3086"/>
<end position="3088"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="3090"/>
<end position="3101"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="3102"/>
<end position="3104"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3112"/>
<end position="3117"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="3118"/>
<end position="3120"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3121"/>
<end position="3124"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="3127"/>
<end position="3129"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3130"/>
<end position="3133"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3157"/>
<end position="3160"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="3168"/>
<end position="3170"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3172"/>
<end position="3177"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="3180"/>
<end position="3182"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="3183"/>
<end position="3185"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3188"/>
<end position="3194"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="3196"/>
<end position="3203"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="3216"/>
<end position="3223"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1XKE"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LAS"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UIN"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UIP"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4GA0"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I9Y"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4L6E"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4LQW"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CLL"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9ERU9"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00156"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00164"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00322"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00339"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10078529"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11792325"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11839768"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12032081"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14729961"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15378033"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15388847"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15608651"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15826666"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15931224"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16332688"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19118815"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20005110"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20386726"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20676357"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22155184"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22194619"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22959972"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23041776"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23353830"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7603572"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7775481"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10078529"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000305"/>
<sequence length="3224" mass="358199" checksum="4CD9A3D5E77183FB" modified="2005-12-06" version="2">MRRSKADVERYIASVQGSTPSPRQKSMKGFYFAKLYYEAKEYDLAKKYICTYINVQERDPKAHRFLGLLYELEENTDKAVECYRRSVELNPTQKDLVLKIAELLCKNDVTDGRAKYWLERAAKLFPGSPAIYKLKEQLLDCEGEDGWNKLFDLIQSELYVRPDDVHVNIRLVEVYRSTKRLKDAVAHCHEAERNIALRSSLEWNSCVVQTLKEYLESLQCLESDKSDWRATNTDLLLAYANLMLLTLSTRDVQESRELLQSFDSALQSVKSLGGNDELSATFLEMKGHFYMHAGSLLLKMGQHSSNVQWRALSELAALCYLIAFQVPRPKIKLIKGEAGQNLLEMMACDRLSQSGHMLLNLSRGKQDFLKEIVETFANKSGQSALYDALFSSQSPKDTSFLGSDDIGNIDVREPELEDLTRYDVGAIRAHNGSLQHLTWLGLQWNSLPALPGIRKWLKQLFHHLPHETSRLETNAPESICILDLEVFLLGVVYTSHLQLKEKCNSHHSSYQPLCLPLPVCKQLCTERQKSWWDAVCTLIHRKAVPGNVAKLRLLVQHEINTLRAQEKHGLQPALLVHWAECLQKTGSGLNSFYDQREYIGRSVHYWKKVLPLLKIIKKKNSIPEPIDPLFKHFHSVDIQASEIVEYEEDAHITFAILDAVNGNIEDAVTAFESIKSVVSYWNLALIFHRKAEDIENDALSPEEQEECKNYLRKTRDYLIKIIDDSDSNLSVVKKLPVPLESVKEMLNSVMQELEDYSEGGPLYKNGSLRNADSEIKHSTPSPTRYSLSPSKSYKYSPKTPPRWAEDQNSLLKMICQQVEAIKKEMQELKLNSSNSASPHRWPTENYGPDSVPDGYQGSQTFHGAPLTVATTGPSVYYSQSPAYNSQYLLRPAANVTPTKGPVYGMNRLPPQQHIYAYPQQMHTPPVQSSSACMFSQEMYGPPALRFESPATGILSPRGDDYFNYNVQQTSTNPPLPEPGYFTKPPIAAHASRSAESKTIEFGKTNFVQPMPGEGLRPSLPTQAHTTQPTPFKFNSNFKSNDGDFTFSSPQVVTQPPPAAYSNSESLLGLLTSDKPLQGDGYSGAKPIPGGQTIGPRNTFNFGSKNVSGISFTENMGSSQQKNSGFRRSDDMFTFHGPGKSVFGTPTLETANKNHETDGGSAHGDDDDDGPHFEPVVPLPDKIEVKTGEEDEEEFFCNRAKLFRFDVESKEWKERGIGNVKILRHKTSGKIRLLMRREQVLKICANHYISPDMKLTPNAGSDRSFVWHALDYADELPKPEQLAIRFKTPEEAALFKCKFEEAQSILKAPGTNVAMASNQAVRIVKEPTSHDNKDICKSDAGNLNFEFQVAKKEGSWWHCNSCSLKNASTAKKCVSCQNLNPSNKELVGPPLAETVFTPKTSPENVQDRFALVTPKKEGHWDCSICLVRNEPTVSRCIACQNTKSANKSGSSFVHQASFKFGQGDLPKPINSDFRSVFSTKEGQWDCSACLVQNEGSSTKCAACQNPRKQSLPATSIPTPASFKFGTSETSKTLKSGFEDMFAKKEGQWDCSSCLVRNEANATRCVACQNPDKPSPSTSVPAPASFKFGTSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEASATKCIACQNPGKQNQTTSAVSTPASSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEASATKCIACQNPGKQNQTTSAVSTPASSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEASATKCIACQCPSKQNQTTAISTPASSEISKAPKSGFEGMFIRKGQWDCSVCCVQNESSSLKCVACDASKPTHKPIAEAPSAFTLGSEMKLHDSSGSQVGTGFKSNFSEKASKFGNTEQGFKFGHVDQENSPSFMFQGSSNTEFKSTKEGFSIPVSADGFKFGISEPGNQEKKSEKPLENGTGFQAQDISGQKNGRGVIFGQTSSTFTFADLAKSTSGEGFQFGKKDPNFKGFSGAGEKLFSSQYGKMANKANTSGDFEKDDDAYKTEDSDDIHFEPVVQMPEKVELVTGEEDEKVLYSQRVKLFRFDAEVSQWKERGLGNLKILKNEVNGKLRMLMRREQVLKVCANHWITTTMNLKPLSGSDRAWMWLASDFSDGDAKLEQLAAKFKTPELAEEFKQKFEECQRLLLDIPLQTPHKLVDTGRAAKLIQRAEEMKSGLKDFKTFLTNDQTKVTEEENKGSGTGAAGASDTTIKPNPENTGPTLEWDNYDLREDALDDSVSSSSVHASPLASSPVRKNLFRFGESTTGFNFSFKSALSPSKSPAKLNQSGTSVGTDEESDVTQEEERDGQYFEPVVPLPDLVEVSSGEENEQVVFSHRAKLYRYDKDVGQWKERGIGDIKILQNYDNKQVRIVMRRDQVLKLCANHRITPDMTLQNMKGTERVWLWTACDFADGERKVEHLAVRFKLQDVADSFKKIFDEAKTAQEKDSLITPHVSRSSTPRESPCGKIAVAVLEETTRERTDVIQGDDVADATSEVEVSSTSETTPKAVVSPPKFVFGSESVKSIFSSEKSKPFAFGNSSATGSLFGFSFNAPLKSNNSETSSVAQSGSESKVEPKKCELSKNSDIEQSSDSKVKNLFASFPTEESSINYTFKTPEKAKEKKKPEDSPSDDDVLIVYELTPTAEQKALATKLKLPPTFFCYKNRPDYVSEEEEDDEDFETAVKKLNGKLYLDGSEKCRPLEENTADNEKECIIVWEKKPTVEEKAKADTLKLPPTFFCGVCSDTDEDNGNGEDFQSELQKVQEAQKSQTEEITSTTDSVYTGGTEVMVPSFCKSEEPDSITKSISSPSVSSETMDKPVDLSTRKEIDTDSTSQGESKIVSFGFGSSTGLSFADLASSNSGDFAFGSKDKNFQWANTGAAVFGTQSVGTQSAGKVGEDEDGSDEEVVHNEDIHFEPIVSLPEVEVKSGEEDEEILFKERAKLYRWDRDVSQWKERGVGDIKILWHTMKNYYRILMRRDQVFKVCANHVITKTMELKPLNVSNNALVWTASDYADGEAKVEQLAVRFKTKEVADCFKKTFEECQQNLMKLQKGHVSLAAELSKETNPVVFFDVCADGEPLGRITMELFSNIVPRTAENFRALCTGEKGFGFKNSIFHRVIPDFVCQGGDITKHDGTGGQSIYGDKFEDENFDVKHTGPGLLSMANQGQNTNNSQFVITLKKAEHLDFKHVVFGFVKDGMDTVKKIESFGSPKGSVCRRITITECGQI</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

